Literature DB >> 3428669

Investigation of intestine function during acute viral hepatitis using combined sugar oral loads.

G Parrilli1, R Cuomo, G Nardone, G Maio, C M Izzo, G Budillon.   

Abstract

One fifth of all cases of A virus hepatitis (AVH) have symptoms of gastroenteritis at the onset. This study investigated the mediated intestinal absorption of D-xylose (D-xyl) and 3-o-methyl-D-glucose (3-omG) and the non-mediated permeation of lactulose (Lacl, mol wt 342) and L-rhamnose (L-rh, mol wt 164) during acute and remission phases of AVH. Ten patients with AVH were given an oral load containing these sugars (5 g D-xyl: 2.5 g 3-omG, 1 g L-rh, 5 g lacl in 250 ml water) once during the acute phase and again during remission. The same load was given once to a group of 22 healthy controls. The mean concentration of D-xyl in urine and the ratio of D-xyl to 3-omG in plasma and urine were normal in both the AVH phases, ruling out intestinal malabsorption even in the acute phase. This study showed a significant increase in non-mediated permeation to Lacl, but not to L-rh, during the acute phase. These data indicate that the barrier function of the intestine is compromised in AVH infection while the absorptive function is not. An abnormally low concentration of D-xyl and 3-omG in plasma at one hour was found in all patients during the acute phase. This finding cannot be explained by alterations in intestinal absorption, but could be accounted for by increased space distribution of the sugars because of increased diffusion into tissue cells and/or expansion of the extracellular space by fluid retention.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3428669      PMCID: PMC1433697          DOI: 10.1136/gut.28.11.1439

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Sugar absorption tests, with special reference to 3-0-methyl-d-glucose and d-xylose.

Authors:  J S FORDTRAN; P H CLODI; K H SOERGEL; F J INGELFINGER
Journal:  Ann Intern Med       Date:  1962-12       Impact factor: 25.391

2.  Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals.

Authors:  V S Chadwick; S F Phillips; A F Hofmann
Journal:  Gastroenterology       Date:  1977-08       Impact factor: 22.682

3.  Estimation of disaccharides in plasma and urine by gas-liquid chromatography.

Authors:  M F Laker
Journal:  J Chromatogr       Date:  1979-05-01

4.  Hepatitis A and meningoencephalitis.

Authors:  K Bromberg; D N Newhall; G Peter
Journal:  JAMA       Date:  1982-02-12       Impact factor: 56.272

5.  Changes in intestinal permeability to lactulose induced by cytotoxic chemotherapy.

Authors:  G Parrilli; R V Iaffaioli; G Capuano; G Budillon; A R Bianco
Journal:  Cancer Treat Rep       Date:  1982-06

6.  Membrane lipid composition and susceptibility to bile salt damage.

Authors:  R Coleman; P J Lowe; D Billington
Journal:  Biochim Biophys Acta       Date:  1980-06-20

7.  Abnormal intestinal permeability to sugars in villous atrophy.

Authors:  I S Menzies; M F Laker; R Pounder; J Bull; S Heyer; P G Wheeler; B Creamer
Journal:  Lancet       Date:  1979-11-24       Impact factor: 79.321

8.  Intestinal permeability in patients with eczema and food allergy.

Authors:  P G Jackson; M H Lessof; R W Baker; J Ferrett; D M MacDonald
Journal:  Lancet       Date:  1981-06-13       Impact factor: 79.321

9.  Cholecystokinin and human intestinal permeability.

Authors:  G Budillon; G Parrilli; L D'Agostino; G Capuano; G Mazzacca; I S Menzies
Journal:  Digestion       Date:  1980       Impact factor: 3.216

10.  Evaluation of xylose absorption as measured in blood and urine: a one-hour blood xylose screening test in malabsorption.

Authors:  M R Haeney; L S Culank; R D Montgomery; H G Sammons
Journal:  Gastroenterology       Date:  1978-09       Impact factor: 22.682

View more
  5 in total

1.  Intestinal permeability after single dose gluten challenge in coeliac disease.

Authors:  L Greco; G D'Adamo; A Truscelli; G Parrilli; M Mayer; G Budillon
Journal:  Arch Dis Child       Date:  1991-07       Impact factor: 3.791

2.  Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD).

Authors:  Valentina Volynets; Markus A Küper; Stefan Strahl; Ina B Maier; Astrid Spruss; Sabine Wagnerberger; Alfred Königsrainer; Stephan C Bischoff; Ina Bergheim
Journal:  Dig Dis Sci       Date:  2012-03-17       Impact factor: 3.199

Review 3.  Intestinal permeability.

Authors:  I Bjarnason
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

4.  Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes.

Authors:  C Pignata; G Budillon; G Monaco; E Nani; R Cuomo; G Parrilli; F Ciccimarra
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

5.  Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea.

Authors:  J Keating; I Bjarnason; S Somasundaram; A Macpherson; N Francis; A B Price; D Sharpstone; J Smithson; I S Menzies; B G Gazzard
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.